Equities

Khiron Life Sciences Corp

Khiron Life Sciences Corp

Actions
  • Price (CAD)0.04
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change--
  • Beta2.8515
Data delayed at least 15 minutes, as of May 09 2023.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Share price forecast

The one analyst offering a 12 month price target expects Khiron Life Sciences Corp share price to rise to 0.10 in the next year from the last price of 0.04.
High150.0%0.10
Med150.0%0.10
Low150.0%0.10

Earnings history & estimates in CAD

On Nov 30, 2022, Khiron Life Sciences Corp reported 3rd quarter 2022 losses of -0.02 per share.
Average growth rate-100.00%
Khiron Life Sciences Corp reported annual 2021 losses of -0.20 per share on May 02, 2022.
Average growth rate+19.58%
More ▼

Revenue history & estimates in CAD

Khiron Life Sciences Corp. had 3rd quarter 2022 revenues of 3.39m. This missed the 4.80m consensus estimate of the 2 analysts following the company. This was 19.32% above the prior year's 3rd quarter results.
Average growth rate+0.76%
Khiron Life Sciences Corp. had revenues for the full year 2021 of 12.80m. This was 59.60% above the prior year's results.
Average growth rate+382.34%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.